Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Monoclonal IgM Antibodies Targeting Candida albicans Hyr1 Provide Cross-Kingdom Protection Against Gram-Negative Bacteria.
Front Immunol. 2020 Feb 18;11:76. doi: 10.3389/fimmu.2020.00076. eCollection 2020.
Front Immunol. 2020.
PMID: 32153560
Free PMC article.
Preserving Vascular Integrity Protects Mice against Multidrug-Resistant Gram-Negative Bacterial Infection.
Gebremariam T, Zhang L, Alkhazraji S, Gu Y, Youssef EG, Tong Z, Kish-Trier E, Bajji A, de Araujo CV, Rich B, French SW, Li DY, Mueller AL, Odelberg SJ, Zhu W, Ibrahim AS.
Gebremariam T, et al.
Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00303-20. doi: 10.1128/AAC.00303-20. Print 2020 Jul 22.
Antimicrob Agents Chemother. 2020.
PMID: 32393494
Free PMC article.
Item in Clipboard
The Hyr1 protein from the fungus Candida albicans is a cross kingdom immunotherapeutic target for Acinetobacter bacterial infection.
Uppuluri P, Lin L, Alqarihi A, Luo G, Youssef EG, Alkhazraji S, Yount NY, Ibrahim BA, Bolaris MA, Edwards JE Jr, Swidergall M, Filler SG, Yeaman MR, Ibrahim AS.
Uppuluri P, et al.
PLoS Pathog. 2018 May 10;14(5):e1007056. doi: 10.1371/journal.ppat.1007056. eCollection 2018 May.
PLoS Pathog. 2018.
PMID: 29746596
Free PMC article.
Item in Clipboard
Cite
Cite